Welch & Forbes LLC Biogen Inc. Transaction History

Welch & Forbes LLC

$7.33 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$223.92 - $287.77 $173,761 - $223,309	-776 Closed	0 $0
Q3 2021 Oct 13, 2021	SELL	$282.99 - $369.05 $42,448 - $55,357	-150 Reduced 16.2%	776 $220,000
Q2 2021 Jul 22, 2021	SELL	$259.0 - $414.71 $172,235 - $275,782	-665 Reduced 41.8%	926 $321,000
Q1 2021 Apr 14, 2021	SELL	$242.95 - $284.63 $14,577 - $17,077	-60 Reduced 3.63%	1,591 $446,000
Q2 2020 Jul 15, 2020	SELL	$258.66 - $342.55 $103,464 - $137,020	-400 Reduced 19.5%	1,651 $442,000
Q1 2020 Apr 17, 2020	BUY	$268.85 - $341.04 $1,344 - $1,705	5 Added 0.24%	2,051 $649,000
Q4 2019 Jan 17, 2020	SELL	$220.06 - $304.07 $60,516 - $83,619	-275 Reduced 11.85%	2,046 $607,000
Q3 2019 Oct 11, 2019	SELL	$217.44 - $243.88 $56,534 - $63,408	-260 Reduced 10.07%	2,321 $540,000
Q2 2019 Jul 12, 2019	SELL	$219.29 - $241.72 $211,614 - $233,259	-965 Reduced 27.21%	2,581 $603,000
Q1 2019 Apr 29, 2019	SELL	$216.71 - $338.96 $692,821 - $1.08 Million	-3,197 Reduced 47.41%	3,546 $838,000
Q4 2018 Feb 05, 2019	SELL	$278.5 - $352.75 $66,840 - $84,660	-240 Reduced 3.44%	6,743 $2.03 Million
Q3 2018 Oct 17, 2018	SELL	$293.51 - $383.83 $280,889 - $367,325	-957 Reduced 12.05%	6,983 $2.47 Million
Q2 2018 Jul 16, 2018	BUY	$257.52 - $306.91 $14,421 - $17,186	56 Added 0.71%	7,940 $2.31 Million
Q1 2018 Apr 12, 2018	BUY	$260.13 - $367.91 $166,743 - $235,830	641 Added 8.85%	7,884 $2.16 Million
Q4 2017 Jan 26, 2018	SELL	$307.64 - $344.58 $130,131 - $145,757	-423 Reduced 5.52%	7,243 $2.31 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $2.16 Million - $2.53 Million	7,666	7,666 $2.4 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account